Safety Profile of Primary Intragastric Balloon Placement in Class III Obesity: An MBSAQIP Analysis of 4,555 Patients
-
By
-
March 15, 2026
Objective:
To investigate the association of Class III obesity with short-term procedural risk by comparing 30-day healthcare utilization and specific risks such as complications and hospital length of stay in patients undergoing intragastric balloon (IGB) placement.
Key Findings:
- The study included a total of 4,555 patients, with a significant focus on those with Class III obesity (BMI ≥ 40 kg/m²), highlighting the need for tailored clinical approaches.
- Short-term procedural risks were assessed, including hospital length of stay and rates of complications, indicating a need for careful monitoring.
- Findings indicated that patients with Class III obesity may experience different outcomes compared to those with lower BMI, suggesting a potential need for revised clinical guidelines.
Interpretation:
The results suggest that while IGB therapy is generally safe, the specific risks associated with Class III obesity warrant careful consideration in clinical practice, and further research is needed to explore long-term outcomes.
Limitations:
- The study is retrospective and may be subject to selection bias, and potential confounding factors such as comorbidities were not fully accounted for.
- Data on long-term outcomes post-IGB removal were not included, limiting the understanding of the therapy's effectiveness over time.
Conclusion:
Clarifying the safety profile of IGBs in Class III obesity patients is crucial for informed patient selection and counseling, potentially enhancing the role of IGBs as a preoperative strategy, and guiding future research and clinical practice.
